Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Development and commercialization of novel therapeutics to treat serious unmet medical needs29.62M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States26.11M88.16%
Europe6.27M21.17%
China91K0.31%
Japan-2.85M-9.64%